| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872521 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 9 Pages |
Abstract
Conclusion: In selected patients with Hodgkin's lymphoma and non-Hodgkin's lymphoma involving the mediastinum, IMRT provides improved planning target volume coverage and reduces pulmonary toxicity parameters. It is feasible for RT of large treatment volumes and allows repeat RT of relapsed disease without exceeding cord tolerance. Additional follow-up is necessary to determine whether improvements in dose delivery affect long-term morbidity and disease control.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Karyn A. M.D., Sean M.S., Margie M.S., Elisa J. M.D., Joachim M.D.,